Searchable abstracts of presentations at key conferences in endocrinology

ea0089c29 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI the Detection of VHL-related Pheochromocytoma

Jha Abhishek , Patel Mayank , Ling Alexander , Chen Clara C. , Millo Corina , Charles Kailah , Talvacchio Sara , Ezemobi Josephine , Herscovitch Peter , Lin Frank I. , Nilubol Naris , Taieb David , Cahid Civelek Ali , Carrasquillo Jorge , Pacak Karel

Background: The purpose of this prospective study was to evaluate and compare the detection rates of 18F-L-dihydroxyphenylalanine (18F-FDOPA), 68Ga-DOTATATE, 18F-FDG, and 18F-fluorodopamine (18F-FDA) PET or positron emission tomography/computed tomography (PET/CT), computed tomography (CT), and magnetic resonance imaging (MRI) in the detection of VHL-related pheochromocytoma (PHEO).<p class="abstext...

ea0049oc7.3 | Cardiovascular endocrinology (1) | ECE2017

High Total 68Ga-DOTATATE-Avid Tumor Volume (TV) is associated with low progression-free survival and high disease-specific mortality rate in patients with neuroendocrine tumors

Tirosh Amit , Papadakis Georgios Z. , Millo Corina , Sadowski Samira M. , Herscovitch Peter , Pacak Karel , Marx Stephen J. , Yang Lily , Nockel Pavel , Shell Jasmine , Green Patience , Keutgen Xavier M. , Patel Dhaval , Nilubol Naris , Kebebew Electron

Background: Patients with neuroendocrine tumors (NETs) have divergent survival, even when having the same site of primary tumor, and tumor stage and grade. 68Gallium (68Ga)-DOTATATE positron emission tomography (PET)/computed tomography (CT) is a sensitive imaging modality for detecting NETs. The purpose of this study was to determine whether 68Ga-DOTATATE PET/CT imaging has any prognostic utility in patients with NETs.Methods: One hundred and eighty-fou...

ea0098c21 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

Ratio of total uptake volume on DOTATATE vs FDG PET as a predictive marker of treatment efficacy of Lu-177-DOTATATE in metastatic pheochromocytoma

Lin Frank I. , Del Rivero Jaydira , Carrasquillo Jorge , Shamis Inna , Zou Joy , Turkbey Baris , Jha Abhishek , Klubo Joanna , Adler Steve , Mena Esther , Lindenberg Liza , Chen Clara , Herscovitch Peter , Millo Corina , Pacak Karel

Background: Pheochromocytoma/Paraganglioma (PPGL) are rare neuroendocrine tumors that expresses somatostatin receptors (SSTR) and can be treated with radiolabeled somatostatin analogues such as Lu-177-DOTATATE. Ga-68-DOTATATE PET scans show the distribution and density of SSTR+ tumors, and F-18-FDG PET scans show hypermetabolism in lesions. Total uptake volumes (TUV) for each respective scan can be obtained consistently and semi-automatically using standardized workflow in ima...

ea0098c22 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

Phase 2 trial of lu-177-DOTATATE in metastatic or inoperable pheochromocytoma/paraganglioma: interim analysis results

Lin Frank I. , Del Rivero Jaydira , Carrasquillo Jorge , Shamis Inna , Zou Joy , Turkbey Baris , Jha Abhishek , Klubo Joanna , Teng Ya-ting , Mena Esther , Lindenberg Liza , Chen Clara , Herscovitch Peter , Millo Corina , Pacak Karel

Background: Pheochromocytoma/Paraganglioma (PPGL) are rare neuroendocrine tumors that expresses somatostatin receptors (SSTR) and can be treated with radiolabeled somatostatin analogues such as Lu-177-DOTATATE. This study is the first prospective study to examine the safety and efficacy of Lu-177-DOTATATE in the treatment of metastatic or inoperable PPGL in a phase 2 clinical trial setting, and results from a planned interim analysis are presented.Method...

ea0098t7 | Trials In Progress | NANETS2023

Phase 1 trial of Pb-212-VMT-alpha-NET in select metastatic or inoperable somatostatin receptor positive tumors

Lin Frank I. , Del Rivero Jaydira , Thomas Anish , Srinivasan Ramaprasad , Charalampos Floudas , Carrasquillo Jorge , Shamis Inna , Zou Joy , Turkbey Baris , Mena Esther , Lindenberg Liza , Chen Clara , Herscovitch Peter , Millo Corina , Pacak Karel

Background: Somatostatin receptors (SSTR) is overexpressed in a number of different tumors, including GI Neuroendocrine Tumors (GI-NET), Pheochromocytoma/Paraganglioma (PPGL), small cell lung cancer (SCLC), renal cell carcinoma (RCC), and certain head and neck cancers (H&N) such as olfactory neuroblastoma. It has been demonstrated that these SSTR-expressing tumors can be treated with beta-emitting radioligand therapy (RLT) that binds to SSTR such as Lu-177-DOTATATE. Howeve...

ea0066oc6.4 | Oral Communications 6 | BSPED2019

Exam preparedness in students with type 1 diabetes and their schools – a quality improvement study

Yard Hannah , Bretland Corrina , Shetty Ambika

Introduction: Type 1 diabetes (T1D) is a lifelong condition affecting over 29 000 children in the United Kingdom, the majority of whom are in full time education. Both hypoglycaemia and hyperglycaemia have been shown to impact the young person’s overall school performance and learning capacity. During exams, children and young people (CYP) with T1D have the additional stress of managing their diabetes appropriately, and therefore require special provisions. Currently, the...

ea0034p163 | Growth and development | SFEBES2014

C-type natriuretic peptide regulates growth and pituitary development in the zebrafish (Danio rerio)

Lessey Andrew , Mirczuk Samantha , McGonnell Imelda , Fowkes Robert

C-type natriuretic peptide (CNP), the predominant natriuretic peptide in the pituitary, is associated with neuroendocrine development and function. Our previous studies show that genes encoding CNP (nppc2, cnp3, nppc4, and nppcl) are expressed during pituitary development in humans and zebrafish (Danio rerio), however a precise role for CNP in the pituitary has yet to be elucidated. Using the versatile zebrafish, we explored in ...

ea0089c27 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT, CT, and MRI Spine in the Detection of Spinal Bone Metastases in Metastatic Pheochromocytoma/Paraganglioma

Jha Abhishek , Patel Mayank , Saboury Babak , Millo Corina , Ling Alexander , Shah Ritu , Chen Clara C. , Meuter Leah , Talvacchio Sara , Knue Marianne , Lin Frank I. , O'Sullivan Coyne Geraldine , Chen Alice P. , Nilubol Naris , Herscovitch Peter , Taieb David , Cahid Civelek Ali , Carrasquillo Jorge A. , Pacak Karel

Background: To evaluate and compare the diagnostic performance of 68Ga-DOTATATE PET/CT to 18F-FDG PET/CT, CT of neck, chest, abdomen and pelvis (CT), and MRI of cervical, thoracic, and lumbar spine (MRI spine), for the detection of spinal bone metastases in metastatic pheochromocytoma and/or paraganglioma (PPGL).Methods: Between 2014 and 2019, 41 consecutive metastatic PPGL patients (19 females; mean age, 43 years) underwent 68...

ea0090p219 | Thyroid | ECE2023

Graves ophthalmopathy in HIV patient: a case report

Seremet Aristia , Vudu Stela , Vudu Lorina

Background: Graves disease is a resurgent autoimmune condition that is known to occur during treatment and immune reconstitution in HIV, and it is one of the commonly diagnosed endocrinopathies in these patients. Graves orbitopathy, on the other hand, is a situation that occurs less frequently. We report the clinical features and manifestations of thyroid-associated orbitopathy in a case of an HIV patient with Graves disease.Case Presentation: A 48-year-...

ea0090p220 | Thyroid | ECE2023

C-reactive protein level in patients with autoimmune hypothyroidism before and after levothyroxine treatment

Vudu Stela , Seremet Aristia , Vudu Lorina

Hypothyroidism is one of the most common endocrine disorders. The long-time debatable question is whether patients with subclinical hypothyroidism (SH) should be treated with levothyroxine. Data are contradictory and treatment decision depends on several factors: TSH level, anti-TPO level, age, presence of symptoms etc. Hypothyroidism is associated with cardiovascular disease. Even a minor increase in C-reactive protein (CRP) is considered a cardiovascular risk, therefore evid...